Jonathan C. Javitt - 24 May 2021 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Jonathan C. Javitt
Issuer symbol: NRXP
Transactions as of: 24 May 2021
Net transactions value: $0
Form type: 3
Filing time: 10 Jun 2021, 18:32:59 UTC
Next filing: 02 Jun 2022
SEC: View on sec.gov

No securities are beneficially owned.